These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer. Vairaktaris E; Yapijakis C; Tsigris C; Vassiliou S; Derka S; Nkenke E; Spyridonidou S; Vylliotis A; Vorris E; Ragos V; Neukam FW; Patsouris E Acta Oncol; 2007; 46(8):1097-102. PubMed ID: 17851834 [TBL] [Abstract][Full Text] [Related]
7. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users. Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834 [TBL] [Abstract][Full Text] [Related]
8. Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients. Supic G; Jovic N; Zeljic K; Kozomara R; Magic Z Oral Oncol; 2012 Nov; 48(11):1171-7. PubMed ID: 22818823 [TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphisms and haplotypes of MMP-14 are associated with the risk and pathological development of oral cancer. Weng CJ; Chen MK; Lin CW; Chung TT; Yang SF Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S319-27. PubMed ID: 21512861 [TBL] [Abstract][Full Text] [Related]
11. A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma. Vairaktaris E; Vassiliou S; Nkenke E; Serefoglou Z; Derka S; Tsigris C; Vylliotis A; Yapijakis C; Neukam FW; Patsouris E Eur J Surg Oncol; 2008 Apr; 34(4):450-5. PubMed ID: 17498910 [TBL] [Abstract][Full Text] [Related]
13. Correlation between functional genotypes in the matrix metalloproteinases-1 promoter and risk of oral squamous cell carcinomas. Lin SC; Chung MY; Huang JW; Shieh TM; Liu CJ; Chang KW J Oral Pathol Med; 2004 Jul; 33(6):323-6. PubMed ID: 15200479 [TBL] [Abstract][Full Text] [Related]
14. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Kietthubthew S; Sriplung H; Au WW; Ishida T Int J Hyg Environ Health; 2006 Jan; 209(1):21-9. PubMed ID: 16373199 [TBL] [Abstract][Full Text] [Related]
15. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma. Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295 [TBL] [Abstract][Full Text] [Related]
16. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort. Srivastava P; Kapoor R; Mittal RD Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201 [TBL] [Abstract][Full Text] [Related]
17. The effect of CCND1 +870A>G and VEGF +936C>T polymorphisms on oral cancer development and disease-free survival in a Taiwan population. Lin YC; Yeh CJ; Wang LH; Lee CW; Chen CH Oral Oncol; 2012 Jun; 48(6):535-40. PubMed ID: 22321253 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Anantharaman D; Chaubal PM; Kannan S; Bhisey RA; Mahimkar MB Carcinogenesis; 2007 Jul; 28(7):1455-62. PubMed ID: 17307803 [TBL] [Abstract][Full Text] [Related]
20. Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. Lin SC; Lo SS; Liu CJ; Chung MY; Huang JW; Chang KW J Oral Pathol Med; 2004 Aug; 33(7):405-9. PubMed ID: 15250832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]